Official Journal of the Italian Society of Orthopaedics and Traumatology
Table 3 Hodges–Lehmann estimates for the confidence intervals for the median differences between the groups
Mediator | Control vs. KL 1–2 | Control vs. KL 3–4 | KL 1–2 vs. KL 3–4 |
|---|---|---|---|
Plasma | |||
NO x | − 8.02 (− 12.05 to − 6.55)* | − 7.48 (− 13.50 to 0.19) | 2.20 (− 2.68 to 6.97) |
IL-1β | − 0.6 (− 1.0 to − 0.2)* | − 0.4 (− 0.8 to 0.1) | 0.2 (− 0.2 to 0.7) |
IL-6 | − 1.97 (− 3.88 to − 0.99)* | − 1.0 (− 2.19 to − 0.22)* | 0.82 (− 0.53 to 2.47) |
IL-18 | 13.88 (− 30.0 to 54.0) | 45.71 (− 13.0 to 107.75) | 26.71 (− 31.0 to 101.75) |
TNFα | 1.0 (0.0 to 2.286)* | − 0.358 (− 3.857 to 1.572) | − 0.857 (− 4.286 to 0.429) |
Uric acid | − 100.16 (− 170.29 to − 44.15)* | − 95.13 (− 156.99 to − 49.66)* | 1.59 (− 65.57 to 70.96) |
Leptin | − 2.18 (− 8.65 to 0.05) | − 7.71 (− 19.64 to − 1.0)* | − 3.28 (− 12.31 to 2.0) |
Synovial fluid | |||
NO x | – | – | − 0.95 (− 3.26 to 0.84) |
IL-1β | – | – | 0.1 (− 0.3 to 2.1) |
IL-6 | – | – | 0 (− 228.56 to 2404.0) |
IL-18 | – | – | − 6.5 (− 21.5 to 16.25) |
TNFα | – | – | 0.429 (− 1.143 to 3.143) |
Uric acid | – | – | − 0.02 (− 58.56 to 63.07) |
Leptin | – | – | − 1.91 (− 7.29 to 7.19) |